Skip to main content
HCPCS J0702 · Level II · Part B drug

J0702: betamethasone acetate (Celestone Soluspan), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0702

Billing unit
3 MG & 3 MG
Betamethasone acet&sod phosp
ASP payment limit
$7.175
October 2026; +0.7% vs July 2026
Practitioner MUE
18
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
2
8 states

TL;DR

HCPCS J0702 is the Level II code for Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg, billed per 3 MG & 3 MG. The Medicare Part B ASP payment limit for October 2026 is $7.175 per billing unit, up 0.7% from July 2026. The practitioner MUE allows up to 18 units per date of service (MAI 3), so a full 18-unit day is $129.15 at the current limit. Under OPPS it carries status indicator N. J0702 is billed in units of 3 MG & 3 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 4 NDCs to it, sold as Celestone Soluspan, Betamethasone Sodium Phosphate and Betamethasone Acetate by American Regent, Inc., Organon LLC. 2 Medicare coverage articles list the code across 5 states plus DC and 2 territories, including A57114.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0702 at $7.175 per 3 MG & 3 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $7.126 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0702
QuarterPayment limitPerCoinsurance
October 2026$7.1753 MG & 3 MG20%
July 2026$7.1263 MG & 3 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 4 NDCs from 2 labelers to J0702. Report the NDC in the claim's drug segment and bill the number of J0702 units that equals the quantity administered divided by 3 MG & 3 MG; the last column gives units per full package.

NDCs that crosswalk to J0702
NDCDrug nameLabelerPackage sizeBilling units / package
00517-0720-01Celestone SoluspanAmerican Regent, Inc.5 × 15
00517-0791-01Betamethasone Sodium Phosphate and Betamethasone AcetateAmerican Regent, Inc.5 × 15
00517-0799-01Betamethasone Sodium Phosphate and Betamethasone AcetateAmerican Regent, Inc.5 × 15
78206-0118-01Celestone SoluspanOrganon LLC5 × 15

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0702. For practitioners the limit is 18 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0702 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services183 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital203 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0702 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0702 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0702 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0702 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

2 current Medicare Administrative Contractor articles list J0702 in their HCPCS tables, covering 8 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J0702
ArticleTitleContractor(s)StatesRelated LCD
A57114Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912
A57751Billing and Coding: Trigger Point InjectionsNovitas Solutions, Inc.DC DE MD NJ PAL35010

Diagnoses Medicare contractors cover for J0702

The 2 articles that list J0702 tie their diagnosis groups to other procedure codes, so no covered ICD-10-CM list is attributed to J0702 itself; the diagnosis has to fit the group written for the procedure billed with the drug. See A57114, A57751.

Local coverage policies that list J0702

2 active Local Coverage Determinations list J0702 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0702 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0702 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0702 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0702

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0702

What does HCPCS code J0702 describe?

J0702 is defined by CMS as "Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg". Each billing unit represents 3 MG & 3 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0702 a CPT code?

No. J0702 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as betamethasone acetate (Celestone Soluspan); CPT codes are five-character codes maintained by the AMA. On a Part B claim J0702 reports the drug itself in 3 mg & 3 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0702 in October 2026?

The ASP-based payment limit is $7.175 per 3 MG & 3 MG, with 20% beneficiary coinsurance. The July 2026 limit was $7.126. Commercial payers use their own fee schedules.

How many units of J0702 can be billed per day?

The practitioner Medically Unlikely Edit is 18 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 20. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J0702?

The October 2026 ASP crosswalk lists 4 NDCs from 2 labelers: Celestone Soluspan (American Regent, Inc.); Betamethasone Sodium Phosphate and Betamethasone Acetate (American Regent, Inc.); Celestone Soluspan (Organon LLC). For example NDC 00517-0720-01 (package size 5) equals 5 billing units of J0702.

Does J0702 have NCCI bundling edits?

No active practitioner PTP pairs list J0702 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J0702?

2 current Billing and Coding Articles in the Medicare Coverage Database list J0702, covering 5 states plus DC and 2 territories: A57114 (Billing and Coding: Trigger Point Injections); A57751 (Billing and Coding: Trigger Point Injections).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.